Jong Pil Im

Associate Professor

Seoul National University Hospital

South Korea

Research Interests

Explore related searches

Professors in South Korea Professors in Immunology Immunology professors in South Korea

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Jong Pil Im is an Associate Professor at Seoul National University Hospital, South Korea. His research focuses on inflammatory bowel disease, including treatment comparisons, disease progression prediction, and the relationships with other health conditions such as nonalcoholic fatty liver disease. He has contributed significantly to understanding the clinical characteristics and long-term prognosis of Crohn's disease among Korean patients.

Articles (15)

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (19)

Jaeyoung Chun

Yonsei University Health System

SOUTH KOREA

Jong Pil Im

Research Interests

Explore related searches

Contact this professor

About

Articles (15)

A real-world comparison of subcutaneous to intravenous administration of infliximab in patients with inflammatory bowel disease

Early Progression Prediction in Korean Crohn’s Disease Using a Korean-Specific PrediXcan Model

Elucidating the association between nonalcoholic fatty liver disease and incidence of inflammatory bowel disease: a focus on systemic inflammation

Predictors of histologic remission in patients with biologic-naïve, moderate-to-severe ulcerative colitis treated with first-line biologic agents and small-molecule drugs: a single-center, retrospective cohort study

Infectious complications in patients with inflammatory bowel disease in Asia: the results of a multinational web-based survey in the 8th Asian Organization for Crohn’s and Colitis meeting

Impact of Crohn’s Disease on the Survival of Patients with Small-Bowel Adenocarcinoma in Korea: A Bicenter Cohort Study

Concomitant ankylosing spondylitis can increase the risk of biologics or small molecule therapies to control inflammatory bowel disease

Enrichment of Activated Fibroblasts as a Potential Biomarker for a Non-Durable Response to Anti-Tumor Necrosis Factor Therapy in Patients with Crohn’s Disease

Clinical Characteristics of Korean Patients with Elderly-Onset Crohn’s Disease: Results from the Prospective CONNECT Study

Clinical Features and Long-term Prognosis of Crohn’s Disease in Korea: Results from the Prospective CONNECT Study

Preventive Effect of Vitamin C on Dextran Sulfate Sodium (DSS)-Induced Colitis via the Regulation of IL-22 and IL-6 Production in Gulo(−/−) Mice

Clinical outcomes and predictors of response for adalimumab in patients with moderately to severely active ulcerative colitis: a KASID prospective multicenter cohort study

Development of a Machine Learning Model to Predict Non-Durable Response to Anti-TNF Therapy in Crohn’s Disease Using Transcriptome Imputed from Genotypes

Clinical Course of Hepatitis B Viral Infection in Patients Undergoing Anti-Tumor Necrosis Factor α Therapy for Inflammatory Bowel Disease

Perspectives of East Asian patients and physicians on complementary and alternative medicine use for inflammatory bowel disease: results of a cross-sectional, multinational study

Collaborators (19)

Jaeyoung Chun

Hyoun Woo Kang

Kang-Moon Lee

Kyuwon Kim

Sung Wook Hwang

Hyun-Soo Kim

Joo Sung Kim

Eun Soo Kim

Byong Duk Ye

Chang Soo Eun

Jae Seung Kang

Min-suk Kim

Dong Il Park

You Sun Kim

Choon Jin Ooi

Jae Myung Cha

Sang-Bum Kang

Jun Lee

Seong-Joon Koh

Make your next move.